Clinical significance of BRAF non-V600E mutations on the therapeutic effects of anti-EGFR monoclonal antibody treatment in patients with pretreated metastatic colorectal cancer: the Biomarker Research for anti-EGFR monoclonal Antibodies by Comprehensive Cancer genomics (BREAC) study.
Br J Cancer
; 117(10): 1450-1458, 2017 Nov 07.
Article
em En
| MEDLINE
| ID: mdl-28972961
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Neoplasias Colorretais
/
Biomarcadores Tumorais
/
Resistencia a Medicamentos Antineoplásicos
/
Proteínas Proto-Oncogênicas B-raf
/
Mutação
/
Antineoplásicos
Idioma:
En
Ano de publicação:
2017
Tipo de documento:
Article